Neurocrine Biosciences (NBIX) Change in Cash (2016 - 2025)
Historic Change in Cash for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $372.8 million.
- Neurocrine Biosciences' Change in Cash rose 42110.25% to $372.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $480.0 million, marking a year-over-year increase of 275193.37%. This contributed to the annual value of $480.0 million for FY2025, which is 275193.37% up from last year.
- Latest data reveals that Neurocrine Biosciences reported Change in Cash of $372.8 million as of Q4 2025, which was up 42110.25% from $76.2 million recorded in Q3 2025.
- In the past 5 years, Neurocrine Biosciences' Change in Cash registered a high of $372.8 million during Q4 2025, and its lowest value of -$256.6 million during Q2 2024.
- In the last 4 years, Neurocrine Biosciences' Change in Cash had a median value of $69.9 million in 2025 and averaged $47.4 million.
- In the last 5 years, Neurocrine Biosciences' Change in Cash crashed by 55335.69% in 2024 and then soared by 42110.25% in 2025.
- Quarter analysis of 4 years shows Neurocrine Biosciences' Change in Cash stood at $165.5 million in 2021, then plummeted by 125.74% to -$42.6 million in 2023, then tumbled by 172.54% to -$116.1 million in 2024, then surged by 421.1% to $372.8 million in 2025.
- Its last three reported values are $372.8 million in Q4 2025, $76.2 million for Q3 2025, and $69.9 million during Q2 2025.